Exact Mass: 470.3508

Exact Mass Matches: 470.3508

Found 41 metabolites which its exact mass value is equals to given mass value 470.3508, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

TG(8:0/8:0/8:0)

Octanoic acid, 1,1,1-(1,2,3-propanetriyl) ester

C27H50O6 (470.3607)


TG(8:0/8:0/8:0) belongs to the family of triradyglycerols, which are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. Their general formula is [R1]OCC(CO[R2])O[R3]. TG(8:0/8:0/8:0) is made up of one octanoyl(R1), one octanoyl(R2), and one octanoyl(R3). It is used in bakery products. Carrier for essential oils and flavours. Glycerol trioctanoate is found in cereals and cereal products. D010592 - Pharmaceutic Aids > D014677 - Pharmaceutical Vehicles > D005079 - Excipients Same as: D01587 Tricaprilin (Trioctanoin) is used in study for patients with mild to moderate Alzheimer's disease and has a role as an anticonvulsant and a plant metabolite[1][2].

   

Triethylhexanoin

1,3-Bis[(2-ethylhexanoyl)oxy]propan-2-yl 2-ethylhexanoic acid

C27H50O6 (470.3607)


D010592 - Pharmaceutic Aids > D014677 - Pharmaceutical Vehicles > D005079 - Excipients

   

2,3-bis(Acetyloxy)propyl icosanoate

2,3-Bis(acetyloxy)propyl icosanoic acid

C27H50O6 (470.3607)


2,3-bis(Acetyloxy)propyl icosanoate belongs to the family of Fatty Acid Esters. These are carboxylic ester derivatives of a fatty acid.

   

N-Stearoyl Tryptophan

3-(1H-indol-3-yl)-2-(octadecanoylamino)propanoic acid

C29H46N2O3 (470.3508)


N-stearoyl tryptophan belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Stearic acid amide of Tryptophan. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Stearoyl Tryptophan is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Stearoyl Tryptophan is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

(+)-(20S)-20-(dimethylamino)-16alpha-hydroxy-3-(3alpha-isopropyl)-lactam-5alpha-pregn-2-en-4-one

(+)-(20S)-20-(dimethylamino)-16alpha-hydroxy-3-(3alpha-isopropyl)-lactam-5alpha-pregn-2-en-4-one

C29H46N2O3 (470.3508)


   

Tricaprylin (C8:0)

Tricaprylin (C8:0)

C27H50O6 (470.3607)


   

Glyceryl trioctanoate

Glyceryl trioctanoate

C27H50O6 (470.3607)


   

Ile Ile Ile Ile

(2S,3S)-2-[(2S,3S)-2-[(2S,3S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylpentanamido]-3-methylpentanamido]-3-methylpentanoic acid

C24H46N4O5 (470.3468)


   

Ile Ile Ile Leu

(2S)-2-[(2S,3S)-2-[(2S,3S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylpentanamido]-3-methylpentanamido]-4-methylpentanoic acid

C24H46N4O5 (470.3468)


   

Ile Ile Leu Ile

(2S,3S)-2-[(2S)-2-[(2S,3S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylpentanamido]-4-methylpentanamido]-3-methylpentanoic acid

C24H46N4O5 (470.3468)


   

Ile Ile Leu Leu

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylpentanamido]-4-methylpentanamido]-4-methylpentanoic acid

C24H46N4O5 (470.3468)


   

Ile Leu Ile Ile

(2S,3S)-2-[(2S,3S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-methylpentanamido]-3-methylpentanamido]-3-methylpentanoic acid

C24H46N4O5 (470.3468)


   

Ile Leu Ile Leu

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-methylpentanamido]-3-methylpentanamido]-4-methylpentanoic acid

C24H46N4O5 (470.3468)


   

Ile Leu Leu Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-methylpentanamido]-4-methylpentanamido]-3-methylpentanoic acid

C24H46N4O5 (470.3468)


   

Ile Leu Leu Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-methylpentanamido]-4-methylpentanamido]-4-methylpentanoic acid

C24H46N4O5 (470.3468)


   

Leu Ile Ile Ile

(2S,3S)-2-[(2S,3S)-2-[(2S,3S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylpentanamido]-3-methylpentanamido]-3-methylpentanoic acid

C24H46N4O5 (470.3468)


   

Leu Ile Ile Leu

(2S)-2-[(2S,3S)-2-[(2S,3S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylpentanamido]-3-methylpentanamido]-4-methylpentanoic acid

C24H46N4O5 (470.3468)


   

Leu Ile Leu Ile

(2S,3S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylpentanamido]-4-methylpentanamido]-3-methylpentanoic acid

C24H46N4O5 (470.3468)


   

Leu Ile Leu Leu

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylpentanamido]-4-methylpentanamido]-4-methylpentanoic acid

C24H46N4O5 (470.3468)


   

Leu Leu Ile Ile

(2S,3S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-methylpentanamido]-3-methylpentanamido]-3-methylpentanoic acid

C24H46N4O5 (470.3468)


   

Leu Leu Ile Leu

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-methylpentanamido]-3-methylpentanamido]-4-methylpentanoic acid

C24H46N4O5 (470.3468)


   

Leu Leu Leu Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-methylpentanamido]-4-methylpentanamido]-3-methylpentanoic acid

C24H46N4O5 (470.3468)


   

Leu Leu Leu Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-methylpentanamido]-4-methylpentanamido]-4-methylpentanoic acid

C24H46N4O5 (470.3468)


   

N-stearoyl tryptophan

N-octadecanoyl-tryptophan

C29H46N2O3 (470.3508)


   

ascr#37

20R-(3R,5R-dihydroxy-6S-methyl-(2H)-tetrahydropyran-2-yloxy)-2E-henicosenoic acid

C27H50O6 (470.3607)


An (omega-1)-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (2E,20R)-20-hydroxyhenicos-2-enoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.

   

oscr#37

21-(3R,5R-dihydroxy-6S-methyl-(2H)-tetrahydropyran-2-yloxy)-2E-henicosenoic acid

C27H50O6 (470.3607)


An omega-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (2E)-21-hydroxyhenicos-2-enoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.

   

2-ethyl-2-[[(1-oxoheptyl)oxy]methyl]propane-1,3-diyl bisheptanoate

2-ethyl-2-[[(1-oxoheptyl)oxy]methyl]propane-1,3-diyl bisheptanoate

C27H50O6 (470.3607)


   

1,2,3-Trioctanoyl Glycerol-13C3

1,2,3-Trioctanoyl Glycerol-13C3

C27H50O6 (470.3607)


   

Eicosanoic acid, 2,3-bis(acetyloxy)propyl ester

Eicosanoic acid, 2,3-bis(acetyloxy)propyl ester

C27H50O6 (470.3607)


   

(2E)-21-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]henicos-2-enoic acid

(2E)-21-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]henicos-2-enoic acid

C27H50O6 (470.3607)


   

(2E,20R)-20-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]henicos-2-enoic acid

(2E,20R)-20-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]henicos-2-enoic acid

C27H50O6 (470.3607)


   

Tricaprilin

Trioctanoylglycerol

C27H50O6 (470.3607)


D010592 - Pharmaceutic Aids > D014677 - Pharmaceutical Vehicles > D005079 - Excipients Same as: D01587 Tricaprilin (Trioctanoin) is used in study for patients with mild to moderate Alzheimer's disease and has a role as an anticonvulsant and a plant metabolite[1][2].

   

[1-carboxy-3-[3-[(4E,7E)-hexadeca-4,7-dienoyl]oxy-2-hydroxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[3-[(4E,7E)-hexadeca-4,7-dienoyl]oxy-2-hydroxypropoxy]propyl]-trimethylazanium

C26H48NO6+ (470.3481)


   

[1-carboxy-3-[3-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-2-hydroxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[3-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-2-hydroxypropoxy]propyl]-trimethylazanium

C26H48NO6+ (470.3481)


   

Trioctanoin

Trioctanoin

C27H50O6 (470.3607)


A triglyceride obtained by acylation of the three hydroxy groups of glycerol by octanoic acid. Used as an alternative energy source to glucose for patients with mild to moderate Alzheimers disease.

   
   
   

TG 8:0/8:0/8:0

TG 8:0/8:0/8:0

C27H50O6 (470.3607)


   

1-{1-[1-(dimethylamino)ethyl]-2-hydroxy-9a,11a-dimethyl-6-oxo-1h,2h,3h,3ah,3bh,4h,5h,5ah,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl}-3-isopropylazetidin-2-one

1-{1-[1-(dimethylamino)ethyl]-2-hydroxy-9a,11a-dimethyl-6-oxo-1h,2h,3h,3ah,3bh,4h,5h,5ah,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl}-3-isopropylazetidin-2-one

C29H46N2O3 (470.3508)


   

(3r)-1-[(1s,2r,3as,3br,5as,9ar,9bs,11as)-1-[(1s)-1-(dimethylamino)ethyl]-2-hydroxy-9a,11a-dimethyl-6-oxo-1h,2h,3h,3ah,3bh,4h,5h,5ah,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]-3-isopropylazetidin-2-one

(3r)-1-[(1s,2r,3as,3br,5as,9ar,9bs,11as)-1-[(1s)-1-(dimethylamino)ethyl]-2-hydroxy-9a,11a-dimethyl-6-oxo-1h,2h,3h,3ah,3bh,4h,5h,5ah,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]-3-isopropylazetidin-2-one

C29H46N2O3 (470.3508)


   

(3r)-1-[(1s,2s,3as,3br,5ar,9ar,9bs,11as)-1-[(1s)-1-(dimethylamino)ethyl]-2-hydroxy-9a,11a-dimethyl-6-oxo-1h,2h,3h,3ah,3bh,4h,5h,5ah,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]-3-isopropylazetidin-2-one

(3r)-1-[(1s,2s,3as,3br,5ar,9ar,9bs,11as)-1-[(1s)-1-(dimethylamino)ethyl]-2-hydroxy-9a,11a-dimethyl-6-oxo-1h,2h,3h,3ah,3bh,4h,5h,5ah,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]-3-isopropylazetidin-2-one

C29H46N2O3 (470.3508)